MedTrace Logo

DEFINITIVE AR Two Year Follow-up Extension Study

NCT02363894 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 53

Last updated 2016-02-02

No results posted yet for this study

Summary

The purpose of this DEFINITIVE AR Two Year Follow-up Extension Study is to gather data to assess and estimate the long term effect of treating a vessel with plaque excision (PE) in combination with paclitaxel-coated balloon angioplasty (PTX PTA) compared to treatment with PTX PTA alone.

Conditions

  • Peripheral Arterial Disease

Sponsors & Collaborators

  • Medtronic Endovascular

    lead INDUSTRY

Principal Investigators

  • Prof. Thomas Zeller, MD · Universitats Herzzentrum Freiburg - Bad Krozingen, Germany

  • Prof. Gunnar Tepe, MD · Klinikum Rosenheim Institut fur Diagnostische und Interventionelle Radiologie - Rosenheim, Germany

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-03-31
Primary Completion
2015-06-30
Completion
2015-06-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02363894 on ClinicalTrials.gov